AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Outlook Therapeutics, Inc.

$0.47 -$0.19 (-29.08%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$0.49
Day Range
$0.45$0.49
Year Range
$0.16$2.54
Market Cap
113.96M
AVG Volume
11.12M
Trailing/Forward PE
-0.43/-
PEG ratio
0.01
Dividend Yield
-
Next Earnings Date
2026-12-18
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
-2M-1M01M2M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
OTLK Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q3-1.16M
26 Q2333.14K
26 Q1205.7K
25 Q41.41M
25 Q31.68M
25 Q2170.12K
25 Q1170.12K
24 Q4170.12K
24 Q30
24 Q20
Net Income (USD) · TTM
-200M-150M-100M-50M050M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
OTLK Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q3-61.12M
26 Q2-60.96M
26 Q1-102.86M
25 Q4-62.42M
25 Q3-43.44M
25 Q221.12M
25 Q1-46.81M
24 Q4-75.37M
24 Q3-94.05M
24 Q2-159.13M
Operating Income (USD) · TTM
-100M-75M-50M-25M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
OTLK Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q3-55.64M
26 Q2-60.57M
26 Q1-58.94M
25 Q4-67.06M
25 Q3-72.62M
25 Q2-76.44M
25 Q1-82.99M
24 Q4-71.7M
24 Q3-61.28M
24 Q2-59.86M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: OTLK

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 18 Dec 2026.

Outlook Therapeutics, Inc.
OTLK
Stockpicker

Video analysis: OTLK

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: OTLK

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.